Last updated on November 2017


Brief description of study


Detailed Study Description

A phase III, randomized, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer) and iron sucrose in subjects with iron deficiency anaemia who are intolerant or unresponsive to oral iron therapy or in whom the haemoglobin measurement in Investigator's opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of receiving a blood transfusion

Clinical Study Identifier: TX11026

Contact Investigators or Research Sites near you

Start Over

Betsy Moclair

Manhattan Medical Research
New York, NY USA

Elena Corona

Grossmont Center for Clinical Research
San Diego, CA USA

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA


Elite Clinical Studies, LLC
Phoenix, AZ USA